Head-to-head · Value Score
bmiMD vs MyDrHank
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, MyDrHank a 63. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#10 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameMyDrHank
#287 · Grade C · Watch List
Est. first month
$249/mo (oral tablet, month-to-month)
Save ~82% vs brand-nameThe verdict
bmiMD takes it on Value Score, 89 to 63 — an est. $99/mo first month, with no teaser step-up baked in. MyDrHank isn't out of it: Shoppers who will genuinely prepay a year up front, want the same price at every dose, and have read past the headline to the $349/$259/$249 month-to-month rates.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | MyDrHank |
|---|---|---|
| Value Score | 89 (A) | 63 (C) |
| Est. first month | $99/mo | $249/mo (oral tablet, month-to-month) |
| Save vs brand-name | ~93% | ~82% |
| Semaglutide | $99/mo | $249/mo oral tablet · $259/mo injectable (month-to-month) |
| Tirzepatide | $139/mo | $349/mo month-to-month (from $240/mo only on the 12-month prepay, $2,883 up front) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Excludes KS, LA, MS, NM, ND and WV; no state list published on the site |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
MyDrHank
A six-shelf compounded telehealth catalogue with both GLP-1 molecules, a real oral tablet and one price at every dose — sold behind headline rates that are all twelve-month prepay, with the month-to-month price shown nowhere.
Why it's a deal
- Both molecules fully priced across all four terms, plus a genuine daily oral tablet — not a sublingual drop
- One price at every dose on the GLP-1 line, so titrating up never raises the bill (this promise is GLP-1 only; the NAD+ and sermorelin lines say pricing depends on the dose prescribed)
- Prices are published before any intake quiz — you can price the program without handing over your details first
- Clean against the FDA warning-letter database under brand, entity and domain; LegitScript-approved with a live verify link, and "Dr. Hank, LLC" is credited as the operator in the privacy policy and terms
The fine print
- ⚠ Every advertised price is the twelve-month prepay rung. Month-to-month is $349 tirzepatide, $259 injectable semaglutide, $249 oral tablet — around 45% above the headline, and printed on no page of the site
- The pricing footnote advertises "$200/mo for compounded tirzepatide" — a rate that exists at no tier the site sells
- The FAQ describes the $171 prepay rate as a plan with "no contract"; it is twelve months bought at once, $2,057 up front
- Compounded only — no FDA-approved Wegovy, Ozempic, Mounjaro or Zepbound route
- No served-states list is published anywhere on the site, and six states are excluded
- Neither the prescriber nor the compounding pharmacy is named — a generic "U.S. board-certified clinician" and "an FDA-registered U.S. pharmacy"
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to MyDrHank.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.